149 related articles for article (PubMed ID: 12617091)
1. Pharmacologic alternatives to transfusion.
Ness PM
Vox Sang; 2002 Aug; 83 Suppl 1():3-6. PubMed ID: 12617091
[No Abstract] [Full Text] [Related]
2. Efficacy of hemostatic agents in improving surgical hemostasis.
Green D; Wong CA; Twardowski P
Transfus Med Rev; 1996 Jul; 10(3):171-82. PubMed ID: 8809968
[No Abstract] [Full Text] [Related]
3. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
4. [Antihemorrhagic prophylaxis in low risk surgery in Bernard-Soulier syndrome].
González González G; Rodríguez Agea E; Ruiz Zafra V
Rev Esp Anestesiol Reanim; 2005 Nov; 52(9):576-7. PubMed ID: 16363308
[No Abstract] [Full Text] [Related]
5. [Indications for the use of platelets, plasma and anti-hemorrhagic drugs].
Mateo J; Muñiz-Díaz E; Fontcuberta J; Madoz P
Rev Esp Anestesiol Reanim; 1992; 39(6):355-61. PubMed ID: 1293653
[TBL] [Abstract][Full Text] [Related]
6. New approaches to management of bleeding disorders.
Aledort LM
Hosp Pract (Off Ed); 1989 Feb; 24(2):207-11, 214, 219-21 passim. PubMed ID: 2493009
[No Abstract] [Full Text] [Related]
7. [Pharmacological alternatives to blood transfusion: what is new about?].
Páramo JA; Lecumberri R; Hernández M; Rocha E
Med Clin (Barc); 2004 Feb; 122(6):231-6. PubMed ID: 15012894
[TBL] [Abstract][Full Text] [Related]
8. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants.
Busuttil RW
J Am Coll Surg; 2003 Dec; 197(6):1021-8. PubMed ID: 14644291
[No Abstract] [Full Text] [Related]
9. Consensus use of desmopressin and antifibrinolytics in three university clinics.
Koscielny J; Blaicher AM; Felfernig D; Latza R; Wenzel E; Kiesewetter H
Anaesthesia; 1998 May; 53 Suppl 2():60-2. PubMed ID: 9659072
[No Abstract] [Full Text] [Related]
10. Novel pharmacologic approaches to reduce bleeding.
Levy JH
Can J Anaesth; 2003; 50(6 Suppl):S26-30. PubMed ID: 14629050
[No Abstract] [Full Text] [Related]
11. High-dose desmopressin in bleeding disorders.
Douglas JT; Shaw J
Eur J Anaesthesiol Suppl; 1997 Mar; 14():v-vi. PubMed ID: 9088827
[No Abstract] [Full Text] [Related]
12. Diagnosis of underlying mechanisms of diffuse microvascular bleeding allows targeted therapy.
Fries D; Innerhofer P;
Eur J Anaesthesiol; 2004 Nov; 21(11):918-9. PubMed ID: 15717712
[No Abstract] [Full Text] [Related]
13. Pharmacological therapies to minimise platelet transfusion.
Norfolk DR; Seghatchian J
Transfus Sci; 2000 Jun; 22(3):149-53. PubMed ID: 10831916
[No Abstract] [Full Text] [Related]
14. Clinical use of hemostatic agents.
Lowe GD; Lawson DH
J Maine Med Assoc; 1978 Mar; 69(3):87-97. PubMed ID: 650082
[No Abstract] [Full Text] [Related]
15. Control of life-threatening head and neck hemorrhage after dental extractions: a case report.
Lieberman BL; Kennedy MK; Lorenzo DR; Reed LJ; Adamo AK; Cardo VA; Badner VM
J Oral Maxillofac Surg; 2010 Sep; 68(9):2311-9. PubMed ID: 20728036
[No Abstract] [Full Text] [Related]
16. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
17. [Drug therapy of hemorrhagic syndromes. Part I].
Ballerini G
Clin Ter; 1974 Jul; 70(2):117-45. PubMed ID: 4409281
[No Abstract] [Full Text] [Related]
18. Massive transfusion and nonsurgical hemostatic agents.
Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
[TBL] [Abstract][Full Text] [Related]
19. Aprotinin--are there lessons learned?
Ferguson TB
JAMA; 2007 Feb; 297(5):527-9. PubMed ID: 17284704
[No Abstract] [Full Text] [Related]
20. Von Willebrand disease. Little known bleeding disorder.
Can Fam Physician; 2001 Jun; 47():1265. PubMed ID: 11421058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
